About the Startup
A neuroscience biotech startup developing small molecule inhibitors targeting mitochondrial dysfunction in neurodegenerative diseases such as ALS and Parkinson's.
Frequently Asked Questions
What type of funding round did NRG Therapeutics raise?
NRG Therapeutics raised a series-b round.
How much did NRG Therapeutics raise in its series-b?
NRG Therapeutics raised $50,000,000 USD in its series-b.
When did NRG Therapeutics raise its series-b?
NRG Therapeutics raised its series-b on 2025-09-08.
Who invested in NRG Therapeutics's series-b?
The investors in NRG Therapeutics's series-b are: SV Health Investors' Dementia Discovery Fund, British Business Bank, M Ventures, Novartis Venture Fund, Criteria Bio Ventures, Omega Funds, Brandon Capital.
What type of investment was NRG Therapeutics's series-b?
NRG Therapeutics's series-b was a equity investment.